Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Preclinical pharmacokinetic evaluation of novel antimalarial and antituberculosis drug leads
Preclinical pharmacokinetics relies on efficient and accurate screening to select clinical candidates from early leads. Poor pharmacokinetic interpretation can disadvantage drug discovery by promoting inadequate compounds and expelling potential drug candidates. Objectives of this project included p...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Chemistry
2019
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Preclinical pharmacokinetic evaluation of novel antimalarial and antituberculosis drug leads
- Supramolecular derivatisation of new anti-tubercular and antimalarial drug leads
- Repurposing chlorpromazine and its metabolites for antituberculosis drug discovery
- The characterization of pharmacokinetic properties and evaluation of in vitro drug combination efficacies of novel antimalarial compounds
- Deconvoluting drug mode-of-action : transcriptomic evaluation of novel clinical lead antimalarials
- In Silico Pharmacokinetic Profile and Antimalarial Efficacy of 3-Chloro-4-(4-Chlorophenoxy)Aniline
- Ethosomes for the Topical Delivery of an Antifungal Drug: Formulation Development, Characterization and Pharmacokinetic Evaluation